Vivek Narayan MD
Hematologic Oncology
Assistant Professor of Medicine, Genitourinary Oncology University of Pennsylvania, Abramson Cancer Center
Join to View Full Profile
3400 Civic Center BlvdPhiladelphia, PA 19104
Phone+1 215-360-0737
Dr. Narayan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Assistant Professor of Medicine, Genitourinary Medical Oncology
University of Pennsylvania, Abramson Cancer Center
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2013 - 2016- University of Pennsylvania Health SystemResidency, Internal Medicine, 2010 - 2013
University of Virginia School of MedicineClass of 2010
Certifications & Licensure
PA State Medical License 2010 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma Start of enrollment: 2017 Jun 29
- Avelumab/Gemcitabine in Sarcomatoid RCC Start of enrollment: 2018 Mar 19
- Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation Therapy Start of enrollment: 2018 Jan 19
- Join now to see all
Publications & Presentations
PubMed
- Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trial.Wonyoung Jung, Rebecca A Hubbard, Amanda M Smith, Kyunga Ko, Anran Huang
Breast Cancer Research and Treatment. 2025-04-02 - Principles of optimal multidisciplinary management of prostate cancer in clinical practice.Filipe Cirne, Michiel Sedelaar, Vivek Narayan, Ariane Macedo, Christopher Koo
Cardio-Oncology. 2025-03-15 - 3 citationsNatural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada
Prostate Cancer and Prostatic Diseases. 2025-03-01
Journal Articles
- Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell CarcinomaPraful Ravi, Charlene Mantia, Christopher Su, Neeraj Agarwal, Yousef Zakharia, Rana R Mckay, Vivek Narayan, Ajjai Alva, Bradley A Mcgregor, David F Mcdermott, Toni K C..., JAMA Oncology
- Original Research Abnormalities in 3-Dimensional Left Ventricular Mechanics with Anthracycline Chemotherapy Are Associated with Systolic and Diastolic DysfunctionKathleen W Zhang, Gaurav Gulati, Hari K Narayan, Jenica Upshaw, W Gregory Hundley, Vivek Narayan, Bonnie Ky, ScienceDirect
Authored Content
- Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell CarcinomaMay 2020
- Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell CarcinomaMay 2020
Press Mentions
Can We Intercept Cancer? A New Frontier in Cancer ResearchFebruary 28th, 2023- PSMA-Directed CAR-T First in Human Trial in Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Vivek NarayanMarch 3rd, 2021
RCC Advances Shake up Drug ChoicesApril 7th, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
